Laidlaw Capital Markets is pleased to have Lead Managed aTyr Pharma’s (LIFE) $86,250,000. Offering alongside Piper Sandler and RBC.

Read Article: https://investors.atyrpharma.com/news-releases/news-release-details/atyr-pharma-announces-pricing-75-million-public-offering-common